Literature DB >> 1885879

Working group recommendations: measuring outcomes of care in geriatric evaluation and management units.

S C Hedrick1, N Barrand, R Deyo, P Haber, K James, J Metter, V Mor, W Scanlon, W Weissert, M Williams.   

Abstract

Issues related to measuring outcomes of care in geriatric evaluation and management (GEM) units were identified by the outcomes working group of the GEM evaluation conference. GEM units have as a major goal the improvement or maintenance of both physical and psychosocial function. Suggested outcome measures for physical health included survival, restricted activity days, general health perceptions, comprehensive physical function, and miscellaneous specific types of functioning. In the area of psycho-social function, the working group suggested measuring cognitive function, affect/life satisfaction, social function, and satisfaction with care. The patient's caregiver (eg, spouse or child) is often an important target of GEM care, and the group suggested measuring caregiver burden, life satisfaction, and assessment of patient behavior problems. While the primary goal of GEM units is to improve health status, their effects on the utilization and cost of health care are important to decisions about wide-spread implementation and funding. The group therefore suggested a comprehensive assessment of these outcomes. Among the large array of recommended outcomes, the most important were thought to be mortality, function, and cost.

Entities:  

Mesh:

Year:  1991        PMID: 1885879     DOI: 10.1111/j.1532-5415.1991.tb05935.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  1 in total

1.  Effectiveness of comprehensive geriatric assessment intervention on quality of life, caregiver burden and length of hospital stay: a systematic review and meta-analysis of randomised controlled trials.

Authors:  Zhongyi Chen; Zhaosheng Ding; Caixia Chen; Yangfan Sun; Yuyu Jiang; Fenglan Liu; Shanshan Wang
Journal:  BMC Geriatr       Date:  2021-06-21       Impact factor: 3.921

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.